FABP5 Informations sur la molécule
Molecule Name
Fatty acid binding protein 5
Alias de la molécule
FABP5,E-FABP,PA-FABP
Drug Development Progress
Nombre de médicaments cliniques1
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 1 Clinical
Alias de la cible
Fatty Acid Binding Protein 5，PA-FABP，E-FABP，Psoriasis-Associated Fatty Acid-Binding Protein Homolog，Fatty Acid Binding Protein 5 (Psoriasis-Associated)，Epidermal-Type Fatty Acid-Binding Protein，Fatty Acid-Binding Protein 5，KFABP，Fatty Acid-Binding Protein， Epidermal，PAFABP，EFABP，FABP5
Contexte de la molécule
Fatty acid-binding protein 5 (FABP5), is also known as Fatty acid-binding protein, epidermal (E-FABP), Psoriasis-associated fatty acid-binding protein homolog (PA-FABP). FABP5 / E-FABP belongs to the calycin superfamily and fatty-acid binding protein (FABP) family. FABP5 / E-FABP is highly expressed in psoriatic skin. FABP5 / E-FABP has high specificity for fatty acids and has highest affinity for C18 chain length. FABP5 may be involved in keratinocyte differentiation.
FABP5 Liste de produits
You Have Viewed 0 Of 0 Results
Informations sur les médicaments cliniques
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| ART-2612 | ART-2612; ART 26.12; ART26.12 | Phase 1 Clinical | Stony Brook University, The Research Foundation of the State University of New York | Anxiety; Breast Neoplasms; Neoplasms; Pain; Peripheral Nervous System Diseases; Prostatic Neoplasms | Details |